ARCHIVES

BRAF Mutation Testing Classifies Indeterminate FNA Samples

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014